News you can use: health & drug safety updates

2007

  • February 9, 2007
    The National Drug Control Policy, (ONDCP) released President Bush’s 2007 National Drug Control Strategy. The Administration’s new Strategy outlines a balanced strategy against illegal drugs, including support for programs that stop drug use before it starts, provide treatment for drug users, and disrupt the market for illegal drugs. According to the Monitoring the Future Study—the largest survey on teen drug use in the United States, as overall drug use has declined in America, prescription drug abuse, particularly among teens, remains troubling. Prescription drug abuse ranks
  • February 2, 2007
    The Agency for Healthcare Research and Quality (AHRQ), has released new consumer and healthcare provider guides that summarize findings of an AHRQ comparative effectiveness review on osteoarthritis pain medications. The guides are written in plain language and draw on a review of 360 published studies. The consumer guide,”Choosing Pain Medication for Osteoarthritis,” summarizes the evidence on both prescription and over-the-counter drugs. It includes information on effectiveness, cost, and potential side effects for non-steroidal anti-

2006

  • December 19, 2006
    The Food and Drug Administration proposed to amend the labeling regulations on over-the-counter (OTC) Internal Analgesic, Antipyretic, and Antirheumatic (IAAA) drug products to include important safety information regarding the potential for stomach bleeding and liver damage and when to consult a doctor. OTC IAAA drug products, commonly known as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, naproxen and ketoprofen, are used to treat pain, fever, headaches, and muscle aches. Click for Questions and Answers
  • November 9, 2006
    The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets. Approximately 11 million bottles containing varying quantities of acetaminophen 500mg caplets are affected by this recall. For a list of batches affected, please see
  • November 7, 2006
    While most prescription drugs marketed in the U.S. have been reviewed and approved as required by FDA, some unapproved prescription drugs are marketed by companies, prescribed by physicians, and taken by patients. Some unapproved drugs, such as phenobarbital, used to control seizures, are very important therapies in the treatment of significant medical conditions and appear to have benefits for patients, so patients should not stop taking an unapproved drug without talking to their doctor first to determine their best treatment options.
  • October 3, 2006
    Annual NCPIE observance works to improve medicine communication/reduce medication errors.
  • September 17, 2006
    The U.S. Food and Drug Administration (FDA) will continue to provide the public with regular updates on the E. coli O157:H7 outbreak each day until further notice. To date, 109 cases of illness due to E. coli infection have been reported to the Centers for Disease Control and Prevention (CDC), including 16 cases of Hemolytic Uremic Syndrome (HUS) and one death. Illnesses continue to be reported to CDC. This is considered to be an ongoing investigation. Symptoms of Illness E. coli O157:H7 causes diarrhea, often with bloody stools. Although most healthy
  • September 8, 2006
    If your doctor told you to take aspirin to help prevent a heart attack, you need to know that taking ibuprofen at the same time, for pain relief, may interfere with the benefits of aspirin for the heart. It is all right to use them together, but the FDA recommends that you contact your doctor for more information on the timing of when to take these two medicines, so that both medicines can be effective.
  • August 30, 2006
    The U.S. Food and Drug Administration (FDA) is advising consumers not to purchase prescription drugs from websites that have orders filled by Mediplan Prescription Plus Pharmacy or Mediplan Global Health in Manitoba, Canada following reports of counterfeit versions of prescription drug products being sold by these companies to U.S. consumers. FDA is investigating these reports and is coordinating with international law enforcement authorities on this matter. FDA recommends that consumers who have purchased drugs from these websites
  • August 24, 2006
    The U.S. Food and Drug Administration (FDA) today announced approval of Plan B, a contraceptive drug, as an over-the-counter (OTC) option for women aged 18 and older. Plan B is often referred to as emergency contraception or the “morning after pill.” It contains an ingredient used in prescription birth control pills—only in the case of Plan B, each pill contains a higher dose and the product has a different dosing regimen. Like other birth control pills, Plan B has been available to all women as a prescription drug. When used as directed, Plan B effectively and

Pages